CIBC Asset Management’s Merck MRK Stock Holding History

CIBC Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89.4M	Buy	742,928 +22,210	+3%	+$2.56M	0.22%	85
2025 Q4	$75.9M	Buy	720,718 +245,419	+52%	+$23M	0.18%	95
2025 Q3	$39.9M	Buy	475,299 +3,968	+0.8%	+$327K	0.12%	127
2025 Q2	$37.3M	Sell	471,331 -78,956	-14%	-$6.28M	0.12%	125
2025 Q1	$49.4M	Buy	550,287 +60,563	+12%	+$5.65M	0.16%	102
2024 Q4	$48.7M	Buy	489,724 +90,691	+23%	+$9.35M	0.16%	104
2024 Q3	$45.3M	Sell	399,033 -6,134	-2%	-$729K	0.15%	109
2024 Q2	$50.2M	Sell	405,167 -88,465	-18%	-$11.4M	0.18%	95
2024 Q1	$65.1M	Buy	493,632 +9,173	+2%	+$1.13M	0.23%	79
2023 Q4	$52.8M	Sell	484,459 -18,651	-4%	-$1.94M	0.2%	90
2023 Q3	$51.8M	Sell	503,110 -8,559	-2%	-$923K	0.21%	85
2023 Q2	$59M	Sell	511,669 -12,431	-2%	-$1.41M	0.23%	82
2023 Q1	$55.8M	Sell	524,100 -8,568	-2%	-$925K	0.22%	81
2022 Q4	$59.1M	Sell	532,668 -109,023	-17%	-$11.1M	0.25%	77
2022 Q3	$55.3M	Buy	641,691 +115,524	+22%	+$10.3M	0.24%	70
2022 Q2	$48M	Sell	526,167 -17,511	-3%	-$1.55M	0.19%	79
2022 Q1	$44.6M	Buy	543,678 +172,587	+47%	+$13.6M	0.16%	94
2021 Q4	$28.4M	Sell	371,091 -139,625	-27%	-$11.1M	0.1%	126
2021 Q3	$38.4M	Sell	510,716 -23,183	-4%	-$1.76M	0.15%	98
2021 Q2	$41.5M	Sell	533,899 -9,809	-2%	-$730K	0.17%	97
2021 Q1	$40M	Buy	543,708 +19,372	+4%	+$1.43M	0.17%	97
2020 Q4	$40.9M	Buy	524,336 +13,968	+3%	+$1.07M	0.19%	94
2020 Q3	$40.4M	Buy	510,368 +3,883	+0.8%	+$304K	0.21%	87
2020 Q2	$37.4M	Buy	506,485 +107,247	+27%	+$8.07M	0.22%	70
2020 Q1	$29.3M	Buy	399,238 +142,038	+55%	+$11.2M	0.21%	72
2019 Q4	$22.3M	Sell	257,200 -13,996	-5%	-$1.15M	0.13%	89
2019 Q3	$21.8M	Sell	271,196 -1,472	-0.5%	-$118K	0.13%	87
2019 Q2	$21.8M	Buy	272,668 +9,069	+3%	+$694K	0.13%	83
2019 Q1	$20.9M	Buy	263,599 +8,667	+3%	+$648K	0.13%	84
2018 Q4	$18.6M	Sell	254,932 -104,283	-29%	-$7.36M	0.14%	77
2018 Q3	$24.3M	Sell	359,215 -425,036	-54%	-$27.1M	0.15%	71
2018 Q2	$45.4M	Sell	784,251 -66,533	-8%	-$3.75M	0.28%	50
2018 Q1	$44.2M	Sell	850,784 -114,966	-12%	-$6.21M	0.29%	48
2017 Q4	$51.9M	Buy	965,750 +611,520	+173%	+$33.9M	0.32%	49
2017 Q3	$21.6M	Sell	354,230 -8,576	-2%	-$520K	0.14%	72
2017 Q2	$22.2M	Sell	362,806 -3,421	-0.9%	-$208K	0.15%	70
2017 Q1	$22.2M	Buy	366,227 +4,071	+1%	+$247K	0.15%	67
2016 Q4	$20.3M	Sell	362,156 -81,285	-18%	-$4.76M	0.15%	70
2016 Q3	$26.4M	Buy	443,441 +11,159	+3%	+$653K	0.19%	59
2016 Q2	$23.8M	Buy	432,282 +7,823	+2%	+$416K	0.18%	67
2016 Q1	$21.4M	Sell	424,459 -65,313	-13%	-$3.2M	0.16%	69
2015 Q4	$24.7M	Sell	489,772 -33,598	-6%	-$1.69M	0.2%	64
2015 Q3	$24.7M	Buy	523,370 +145,667	+39%	+$7.74M	0.2%	61
2015 Q2	$20.5M	Buy	377,703 +13,139	+4%	+$737K	0.14%	73
2015 Q1	$20M	Buy	364,564 +841	+0.2%	+$47.6K	0.14%	69
2014 Q4	$19.7M	Sell	363,723 -55,961	-13%	-$3.12M	0.13%	68
2014 Q3	$23.7M	Sell	419,684 -9,722	-2%	-$546K	0.14%	64
2014 Q2	$23.7M	Sell	429,406 -10,468	-2%	-$571K	0.13%	70
2014 Q1	$23.8M	Sell	439,874 -29,297	-6%	-$1.52M	0.14%	70
2013 Q4	$22.4M	Sell	469,171 -21,665	-4%	-$990K	0.14%	67
2013 Q3	$22.3M	Buy	490,836 +7,726	+2%	+$353K	0.14%	64
2013 Q2	$21.4M	Buy	+483,110	New	+$21.6M	0.15%	65

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIBC Asset Management's MRK Position: Q1 2026 in Review

CIBC Asset Management increased its Merck (MRK) stake by 3.1% in Q1 2026, buying an estimated $2.56M and bringing the position to 742,928 shares worth $89.4M. The position accounts for 0.22% of the portfolio, ranked #85.

CIBC Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

CIBC Asset Management held 742,928 shares of Merck worth $89.4M as of Q1 2026.
CIBC Asset Management bought 22,210 Merck shares in Q1 2026, an estimated $2.56M.
Merck made up 0.22% of CIBC Asset Management's portfolio in Q1 2026, its #85 holding.
CIBC Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.